PDF herunterladen
Thromb Haemost 2000; 84(06): 1117-1118
DOI: 10.1055/s-0037-1614180
Letters to the Editor
Schattauer GmbH

The FXIII Val 34 Leu Mutation and the Risk of Venous Thrombosis

Martine Alhenc-Gelas
1   From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris
,
Jean-Luc Reny
1   From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris
,
Marie-Laurence Aubry
1   From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris
,
Martine Aiach
1   From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris
,
Joseph Emmerich
1   From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 26. Juni 2000

Accpeted after revision 16. August 2000

Publikationsdatum:
13. Dezember 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Mikkola H, Syrjala M, Rasi V, Vahtera H, Hamalainen E, Peltonen L. Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on novel transcript levels. Blood 1994; 84: 517-25.
    PubMedGoogle Scholar
  • 2 Kohler HP, Stickland MH, Ossel-Gerning N, Carter A, Mikkola H, Grant P. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 3 Elbaz A, Poirier O, Canaple S, Chedru F, Cambien F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
    PubMedGoogle Scholar
  • 4 Trumbo TA, Maurer MC. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII Val 34 Leu mutation. J Biol Chem. 2000 (in press).
    PubMedGoogle Scholar
  • 5 Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
    PubMedGoogle Scholar
  • 6 Franco RF, Reitsma PH, Lourenco D, Maffei FH, Tavella MH, Araujo AG, Piccinato CE, Zago MA. Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost 1999; 81: 676-9.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 7 Corral J, Gonzalez-Conejero R, Iniesta JA, Rivea J, Martinez C, Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000; 85: 293-7.
    PubMedGoogle Scholar
  • 8 Rosendaal FR, Grant PJ, Ariens RAS, Poort SR, Bertina RM. Factor XIII Val34Leu, factor XIII antigen and activity levels and risk of venous thrombosis. Thromb Haemost 1999; 82: 508-9 (Suppl., abstract 1599).
    PubMedGoogle Scholar
  • 9 Arnaud E, Nicaud V, Poirier O, Rendu F, Alhenc-Gelas M, Fiessinger JN, Emmerich J, Aiach M. Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol 2000; 20: 585-92.
    CrossrefPubMedGoogle Scholar
  • 10 Kangsadalampai S, Board PG. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 1998; 92: 2766-70.
    PubMedGoogle Scholar
  • 11 Cucherat M, Boissel JP, Leizorovicz A, Haugh MC, Easy MA. a program for the meta-analysis of clinical trials. Computer Methods and Programs in Biomedicine 1997; 53: 187-90.
    CrossrefPubMedGoogle Scholar